Cargando…

Association of a Community Population and Clinic Education Intervention Program With Guideline-Based Aspirin Use for Primary Prevention of Cardiovascular Disease: A Nonrandomized Controlled Trial

IMPORTANCE: Low-dose aspirin is used for primary prevention of cardiovascular disease in approximately one-third of the US adult population. Overuse and underuse are common and not concordant with guidelines. OBJECTIVE: To test a community and clinic education intervention to improve guideline-based...

Descripción completa

Detalles Bibliográficos
Autores principales:	Luepker, Russell V., Eder, Milton, Finnegan, John R., Van’t Hof, Jeremy R., Oldenburg, Niki, Duval, Sue
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Medical Association 2022
Materias:	Original Investigation
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9092209/ https://www.ncbi.nlm.nih.gov/pubmed/35536579 http://dx.doi.org/10.1001/jamanetworkopen.2022.11107

Ejemplares similares

News coverage and online advertising effects on patient-led search for aspirin, heart health, and stroke information and educational tool use
por: Southwell, Brian G., et al.
Publicado: (2021)

Contemporary Primary Prevention Aspirin Use by Cardiovascular Disease Risk: Impact of US Preventive Services Task Force Recommendations, 2007—2015: A Serial, Cross‐sectional Study
por: Van't Hof, Jeremy R., et al.
Publicado: (2017)

Estimation of Cardiovascular Risk from Self-Reported Knowledge of Risk Factors: Insights from the Minnesota Heart Survey
por: Duval, Sue, et al.
Publicado: (2020)

A 16-Month Community-Based Intervention to Increase Aspirin Use for Primary Prevention of Cardiovascular Disease
por: Oldenburg, Niki C., et al.
Publicado: (2014)

Promoting Aspirin Use for Cardiovascular Disease Prevention Among an Adult Internet-Using Population: A Pilot Study
por: Oldenburg, Niki C., et al.
Publicado: (2021)

Use of a Geographic Information System to create treatment groups for group-randomized community trials: The Minnesota Heart Health Program
por: Krzyzanowski, Brittany, et al.
Publicado: (2019)

Cost‐Effectiveness of a Statewide Campaign to Promote Aspirin Use for Primary Prevention of Cardiovascular Disease
por: Michaud, Tzeyu L., et al.
Publicado: (2015)

Population Trends in Aspirin Use for Cardiovascular Disease Prevention 1980–2009: The Minnesota Heart Survey
por: Luepker, Russell V., et al.
Publicado: (2015)

An observational study of a clinical guideline implementation project in primary care
por: Eder, Milton “Mickey”, et al.
Publicado: (2019)

Evaluation of an Educational Outreach and Audit and Feedback Program to Reduce Continuous Pulse Oximetry Use in Hospitalized Infants With Stable Bronchiolitis: A Nonrandomized Clinical Trial
por: Schondelmeyer, Amanda C., et al.
Publicado: (2021)

Evaluation of a National Comprehensive Cancer Network Guidelines–Based Decision Support Tool in Patients With Non–Small Cell Lung Cancer: A Nonrandomized Clinical Trial
por: Wu, Susan Y., et al.
Publicado: (2020)

Nonrandom Distribution of Interhomolog Recombination Events Induced by Breakage of a Dicentric Chromosome in Saccharomyces cerevisiae
por: Song, Wei, et al.
Publicado: (2013)

The FReedom from Ischemic Events - New Dimensions for Survival (FRIENDS) registry: design of a prospective cohort study of patients with advanced peripheral artery disease
por: Keo, Hong H, et al.
Publicado: (2013)

The new European guideline on cardiovascular disease prevention; how to make progress in general practice?: Commentary on: Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice
por: Marchal, Suzanne, et al.
Publicado: (2017)

Nivolumab for Patients With High-Risk Oral Leukoplakia: A Nonrandomized Controlled Trial
por: Hanna, Glenn J., et al.
Publicado: (2023)

Using Time-out for Child Conduct Problems in the Context of Trauma and Adversity: A Nonrandomized Controlled Trial
por: Roach, Alex C., et al.
Publicado: (2022)

Assessment of Awake Prone Positioning in Hospitalized Adults With COVID-19: A Nonrandomized Controlled Trial
por: Qian, Edward Tang, et al.
Publicado: (2022)

Evaluation of Aspirin and Statin Therapy Use and Adherence in Patients With Premature Atherosclerotic Cardiovascular Disease
por: Mahtta, Dhruv, et al.
Publicado: (2020)

Avelumab Plus Talazoparib in Patients With Advanced Solid Tumors: The JAVELIN PARP Medley Nonrandomized Controlled Trial
por: Yap, Timothy A., et al.
Publicado: (2022)

Treatment of Opioid Use Disorder in Pregnant Women via Telemedicine: A Nonrandomized Controlled Trial
por: Guille, Constance, et al.
Publicado: (2020)

Evaluation of a Patient-Centered Fall-Prevention Tool Kit to Reduce Falls and Injuries: A Nonrandomized Controlled Trial
por: Dykes, Patricia C., et al.
Publicado: (2020)

Ambroxol for the Treatment of Patients With Parkinson Disease With and Without Glucocerebrosidase Gene Mutations: A Nonrandomized, Noncontrolled Trial
por: Mullin, Stephen, et al.
Publicado: (2020)

Safety and Tolerability of Transdermal Cannabidiol Gel in Children With Developmental and Epileptic Encephalopathies: A Nonrandomized Controlled Trial
por: Scheffer, Ingrid E., et al.
Publicado: (2021)

Evaluation of Nonpharmacologic Interventions and Sleep Outcomes in Hospitalized Medical and Surgical Patients: A Nonrandomized Controlled Trial
por: van den Ende, Eva S., et al.
Publicado: (2022)

Long-term Outcomes of Bevacizumab and Chemoradiation for Locoregionally Advanced Nasopharyngeal Carcinoma: A Nonrandomized Controlled Trial
por: Lee, Nancy Y., et al.
Publicado: (2023)

Community-Based Point-of-Diagnosis Hepatitis C Treatment for Marginalized Populations: A Nonrandomized Controlled Trial
por: Morris, Meghan D., et al.
Publicado: (2023)

Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled Trial
por: Peyrl, Andreas, et al.
Publicado: (2023)

An Evaluation of Aspirin Treatment Preferences of Physicians in Hypertensive Patients in Terms of Current Guidelines: A Subgroup Analysis of the ASSOS Trial in Turkey
por: Memiç Sancar, Kadriye, et al.
Publicado: (2022)

Inappropriate combination of warfarin and aspirin
por: Turan, Burak, et al.
Publicado: (2016)

Effectiveness and Safety of Enteric-Coated vs Uncoated Aspirin in Patients With Cardiovascular Disease: A Secondary Analysis of the ADAPTABLE Randomized Clinical Trial
por: Sleem, Amber, et al.
Publicado: (2023)

Efficacy and Safety of Vamorolone in Duchenne Muscular Dystrophy: A 30-Month Nonrandomized Controlled Open-Label Extension Trial
por: Mah, Jean K., et al.
Publicado: (2022)

Safety and Vision Outcomes of Subretinal Gene Therapy Targeting Cone Photoreceptors in Achromatopsia: A Nonrandomized Controlled Trial
por: Fischer, M. Dominik, et al.
Publicado: (2020)

Patient-Reported Outcomes of Omission of Breast Surgery Following Neoadjuvant Systemic Therapy: A Nonrandomized Clinical Trial
por: Johnson, Helen M., et al.
Publicado: (2023)

Demographic and Clinical Characteristics Associated With the Failure of Nonoperative Management of Uncomplicated Appendicitis in Children: Secondary Analysis of a Nonrandomized Clinical Trial
por: Minneci, Peter C., et al.
Publicado: (2022)

Lack of benefits for prevention of cardiovascular disease with aspirin therapy in type 2 diabetic patients - a longitudinal observational study
por: Leung, Wilson Y, et al.
Publicado: (2009)

Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study
por: Takahashi, Yasuo, et al.
Publicado: (2013)

Effectiveness and Safety of Apatinib Plus Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer: A Nonrandomized Controlled Trial
por: Lin, Jian-Xian, et al.
Publicado: (2021)

Assessment of Pediatric Telemedicine Using Remote Physical Examinations With a Mobile Medical Device: A Nonrandomized Controlled Trial
por: Wagner, Rafaela, et al.
Publicado: (2023)

Antitumor Activity and Safety of Dostarlimab Monotherapy in Patients With Mismatch Repair Deficient Solid Tumors: A Nonrandomized Controlled Trial
por: André, Thierry, et al.
Publicado: (2023)

Assessment of Systemic Delivery of rAAVrh74.MHCK7.micro-dystrophin in Children With Duchenne Muscular Dystrophy: A Nonrandomized Controlled Trial
por: Mendell, Jerry R., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3nc76mg2kskqupua2freb0kd5q